Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TriSalus Life Sciences, Inc. | 147,555 | reported | 15 May 2026 | tx 12+357,697 |
| Coherus Oncology, Inc. | 112,000 | reported | 12 Jun 2025 | tx 56+3,148,889−2,438,970 |
| HEALTH GRADES INC | 0 | reported | 07 Oct 2010 | tx 4+33,500−33,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 May 2026 | PURCHASE | TriSalus Life Sciences, Inc. | 60,000 | 2.53 USD | first after silence |
| 14 May 2026 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 37,602 | 0.00 USD | |
| 14 May 2026 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 34,226 | 0.00 USD | |
| 14 May 2026 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 75,204 | 0.00 USD | deriv |
| 12 Jun 2025 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 15,000 | 0.00 USD | deriv |
| 12 Jun 2025 | GRANT_AWARD | Coherus Oncology, Inc. | 112,000 | 0.00 USD | deriv |
| 23 May 2025 | SALE | Coherus Oncology, Inc. | 99,988 | 0.74 USD | |
| 10 Feb 2025 | OTHER | TriSalus Life Sciences, Inc. | 44,750 | 0.00 USD | deriv |
| 17 Dec 2024 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 25,188 | 3.97 USD | |
| 22 Nov 2024 | PURCHASE | TriSalus Life Sciences, Inc. | 5,000 | 4.55 USD | |
| 21 Nov 2024 | PURCHASE | TriSalus Life Sciences, Inc. | 8,687 | 4.44 USD | |
| 20 Nov 2024 | PURCHASE | TriSalus Life Sciences, Inc. | 2,040 | 4.16 USD | first after silence |
| 13 Aug 2024 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 15,000 | 0.00 USD | deriv |
| 03 Jun 2024 | GRANT_AWARD | Coherus Oncology, Inc. | 112,000 | 0.00 USD | deriv |
| 09 Feb 2024 | GIFT | Coherus Oncology, Inc. | 99,988 | 0.00 USD | |
| 09 Feb 2024 | GIFT | Coherus Oncology, Inc. | 99,988 | 0.00 USD | |
| 01 Feb 2024 | EXERCISE | Coherus Oncology, Inc. | 14,997 | 1.67 USD | |
| 01 Feb 2024 | EXERCISE | Coherus Oncology, Inc. | 44,991 | 1.67 USD | |
| 01 Feb 2024 | EXERCISE | Coherus Oncology, Inc. | 44,991 | 0.00 USD | deriv |
| 01 Feb 2024 | EXERCISE | Coherus Oncology, Inc. | 14,997 | 0.00 USD | deriv |
| 10 Aug 2023 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 35,000 | 0.00 USD | deriv |
| 07 Jun 2023 | GRANT_AWARD | Coherus Oncology, Inc. | 38,250 | 0.00 USD | deriv |
| 25 Feb 2022 | GRANT_AWARD | Coherus Oncology, Inc. | 10,006 | 11.64 USD | |
| 28 Feb 2022 | GRANT_AWARD | Coherus Oncology, Inc. | 29,994 | 2.08 USD | |
| 28 Feb 2022 | EXERCISE | Coherus Oncology, Inc. | 29,994 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 15 May 2026.